NAGEN1000"is a regional pilot study in Spain that aims to apply the latest whole genome sequencing technology in clini-cal practice.The study primarily focuses on patients with rare diseases and their families,providing diagnosis and treatment plans for rare diseases through the analysis of whole genome data,as well as addressing issues related to personalized prevention and drug therapy.The project recruited 1000 rare disease patients and their relatives and has achieved significant results,including the identification of enetic variants associated with preventable severe diseases and the determination of pharmacogenomic variations,and the project has dis-covered some promising candidate genomes,laying the foundation for future new diagnoses and collaborative research projects.This proj-ect demonstrates how translational research and innovation in genomics and personalized medicine benefit real patients,and has been recognized as a"best practice in personalized medicine"by ICPerMed.The project has also led to the establishment of a new genomics medicine department at Navarrabiomed and the NAGEN strategy,providing support for research and development projects in personal-ized medicine,and serving as a model practice for the National Genomics and Personalized Medicine Strategy initiative in the Spanish Senate.Based on the overview of the overall situation of precision medicine in Spain,this study focus on the"NAGEN1000"project,so as to provide readers with a better understanding of the"NAGEN1000"project.
维普
万方数据